SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Apricus Biosciences
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Strong Long who wrote (1946)5/16/2016 3:22:16 PM
From: mokelumne river  Read Replies (1) of 2026
 
>I hope you're right about the efficacy. I do believe that management was trying to get that point across at the KOL event, but the point was lost a bit by the technical nature of the presentation.<

In thinking about it, Dr. Kim should have said the following before getting bogged down in detail:

1. Vitaros has been approved by the European Medicines Agency, the equivalent of the FDA for the European Union.

2. Vitaros has been prescribed by doctors in the EU for the last two years to meet the unmet demand for an effective non-systemic ED drug.

3. I have reviewed the clinical data that were the bases for approval of Vitaros by the European Medicines Agency and I would prescribe Vitaros if approved by the FDA.

4. I hope the FDA approves Vitaros.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News